A Precision Medicine Framework Using Artificial Intelligence for the Identification and Confirmation of Genomic Biomarkers of Response to an Alzheimer's Disease Therapy: Analysis of the Blarcamesine (ANAVEX2‐73) Phase 2a Clinical Study
Alzheimer s & Dementia Translational Research & Clinical Interventions（2020）
Key words
Alzheimer's disease,association rules,biomarker,genomic analysis,knowledge extraction management,machine learning,mixed effect models,precision medicine,unsupervised analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined